Bliss GVS Pharma Limited (BOM:506197)
India flag India · Delayed Price · Currency is INR
519.50
-4.55 (-0.87%)
At close: Aug 17, 2026

Bliss GVS Pharma Cash Flow Statement

Millions INR. Fiscal year is Apr - Mar.

Operating Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Net Income
1,291842.99754.54708.59150.4
Depreciation & Amortization
334.14293.21262.57185.13171.33
Other Amortization
0.690.971.231.611.98
Loss (Gain) From Sale of Assets
21.094.92-2.86-3.65-1.38
Asset Writedown & Restructuring Costs
5.42----
Loss (Gain) From Sale of Investments
339.1225.75---
Stock-Based Compensation
86.2441.438.1639.0457.08
Provision & Write-off of Bad Debts
242.72214.88252.74228.07227.8
Other Operating Activities
110.91149.58187.535.5413.87
Change in Accounts Receivable
-883.65-415.89-445.19-149.98512.91
Change in Inventory
-455-304.54-224.22150.03-290.97
Change in Accounts Payable
326.16108.38-251-63.16183.44
Change in Other Net Operating Assets
-31.9697.49454.7-788.08328.34
Operating Cash Flow
1,3871,0591,028343.141,355
Operating Cash Flow Growth
30.97%3.01%199.64%-74.67%111.79%

Investing Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Capital Expenditures
-568.31-762.86-283.29-937.99-740.03
Sale of Property, Plant & Equipment
25.3534.126.036.9110.68
Cash Acquisitions
-2.23----
Divestitures
85.14----
Investment in Securities
-93.19-191.7539.54-54.58-22.31
Other Investing Activities
170.45164.56-1,094908.15-178.09
Investing Cash Flow
-382.8-755.87-831.9-77.51-929.75

Financing Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Long-Term Debt Issued
42.53552.73154.88400.22107.56
Long-Term Debt Repaid
-693.9-762.34-272.36-552.68-284.81
Net Debt Issued (Repaid)
-651.37-209.61-117.48-152.46-177.26
Issuance of Common Stock
1828.8623.520.4222.84
Common Dividends Paid
-106.37-53.95-53.95-54.37-53.27
Other Financing Activities
-152.38-67.29-61-62.97-29.62
Financing Cash Flow
-892.11-301.98-208.93-249.39-237.3

Net Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Foreign Exchange Rate Adjustments
0.970.99-1.513.96-99.23
Net Cash Flow
113.252.26-14.1630.288.53

Free Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Free Cash Flow
818.87296.27744.87-594.86614.78
Free Cash Flow Growth
176.39%-60.23%--12.09%
Free Cash Flow Margin
8.83%3.66%9.67%-7.92%8.22%
Free Cash Flow Per Share
7.612.797.02-5.645.84
Levered Free Cash Flow
949.59155.0319.06-184.611,059
Unlevered Free Cash Flow
1,025205.7856.88-122.961,082

Additional Metrics

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash Interest Paid
149.3468.216162.9729.62
Cash Income Tax Paid
416.52366.36348.51445.55339.43
Change in Working Capital
-1,044-514.56-465.71-851.19733.73